| A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC (NCT05386888) | Genfleet Therapeutics (Shanghai) Inc. | 2022-09-09 |
| Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer (NCT04931017) | Northwestern University | 2022-09-09 |
| Comparing the Perioperative Analgesic Effect of Two Different Volumes of Local Anesthetic Solution in Erector Spinae Plane Block in Patients Undergoing Modified Radical Mastectomy (NCT05813158) | Cairo University | 2022-09-09 |
| Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes (NCT05414058) | The Royal Ottawa Mental Health Centre | 2022-09-09 |
| An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues (NCT05540392) | Memorial Sloan Kettering Cancer Center | 2022-09-09 |
| A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors (NCT06223308) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2022-09-09 |
| Soluble Fibre Supplementation in NAFLD (NCT05480696) | McMaster University | 2022-09-09 |
| Assessment of the Clinical, Cellular and Molecular Effects of Royalactin-Royal Jelly on the Healing of Wagner Grad II Diabetic Foot Ulcers. (NCT07509268) | Universidad Autonoma de Nuevo Leon | 2022-09-09 |
| Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC. (NCT05620498) | Tianjin Medical University Cancer Institute and Hospital | 2022-09-08 |
| A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations (NCT05560334) | Tianjin Medical University Cancer Institute and Hospital | 2022-09-08 |
| Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis (NCT05570058) | Redx Pharma Ltd | 2022-09-08 |
| Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL (NCT05557110) | Chen Suning | 2022-09-08 |
| Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents (NCT05423483) | University of Texas Southwestern Medical Center | 2022-09-08 |
| Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study (NCT05279092) | Yale University | 2022-09-08 |
| Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma (NCT05625737) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-09-08 |
| Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer (NCT05435053) | Ismail Gögenur | 2022-09-08 |
| A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis (NCT05493488) | DermBiont, Inc. | 2022-09-08 |
| Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System (NCT05419817) | Haider Mahdi | 2022-09-08 |
| Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge (NCT05418049) | Children's Hospital Medical Center, Cincinnati | 2022-09-08 |
| Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD (NCT05621759) | NYU Langone Health | 2022-09-07 |
| Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003) (NCT05507450) | Merck Sharp & Dohme LLC | 2022-09-07 |
| Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy (NCT05440643) | ALK-Abelló A/S | 2022-09-07 |
| Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients (NCT05174832) | Fudan University | 2022-09-07 |
| Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo (NCT05298033) | University of Colorado, Denver | 2022-09-07 |
| 5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk (NCT05385549) | Asan Medical Center | 2022-09-07 |
| Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) (NCT05388760) | LEO Pharma | 2022-09-07 |
| Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain (NCT05054179) | University of British Columbia | 2022-09-07 |
| CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies (NCT05454241) | Institute of Hematology & Blood Diseases Hospital, China | 2022-09-07 |
| Cluster Headache Treatment With Rimegepant (NCT05264714) | Mayo Clinic | 2022-09-07 |
| IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer (NCT06014528) | InxMed (Shanghai) Co., Ltd. | 2022-09-06 |
| A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma (NCT04971499) | April Salama, M.D. | 2022-09-06 |
| Effect of Nitrous Oxide on Aggression. (NCT06118567) | Ohio State University | 2022-09-06 |
| A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer (NCT05534438) | Memorial Sloan Kettering Cancer Center | 2022-09-06 |
| Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) (NCT05489211) | AstraZeneca | 2022-09-06 |
| Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder (NCT05423717) | Idorsia Pharmaceuticals Ltd. | 2022-09-06 |
| Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates (NCT05404919) | University of Pennsylvania | 2022-09-06 |
| De-escalation Study for Stage IIa/IIb < 3 cm Seminoma (NCT05529251) | Centre Leon Berard | 2022-09-06 |
| A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT05489991) | Tceleron Therapeutics, Inc. | 2022-09-06 |
| Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults (NCT05383560) | Sheba Medical Center | 2022-09-05 |
| Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE (NCT05762146) | Maastricht University | 2022-09-05 |
| Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma (NCT05471843) | BeiGene | 2022-09-05 |
| The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy) (NCT05536102) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2022-09-05 |
| Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis (NCT04074096) | UNICANCER | 2022-09-05 |
| Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy (NCT07363031) | Instituto Oncoclinicas | 2022-09-05 |
| Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 (NCT05481879) | Dyne Therapeutics | 2022-09-05 |
| Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 (NCT05508594) | Cessatech A/S | 2022-09-05 |
| Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation (NCT05539521) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-09-05 |
| AI-09 In Subjects With Glabellar Lines, GL-101 (NCT05565950) | Eirion Therapeutics Inc. | 2022-09-03 |
| Pembrolizumab Plus Olaparib in LA-HNSCC (NCT05366166) | UNC Lineberger Comprehensive Cancer Center | 2022-09-02 |
| 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study (NCT05496959) | Jonsson Comprehensive Cancer Center | 2022-09-02 |
| Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease (NCT04987294) | Allena Pharmaceuticals | 2022-09-02 |
| Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy (NCT05605301) | University of Virginia | 2022-09-02 |
| Toripalimab-based Neoadjuvant Therapy in LA-HNSCC (NCT05522985) | Tianjin Medical University Cancer Institute and Hospital | 2022-09-02 |
| Astaxanthin for Management of Inflammation in Knee Osteoarthritis (NCT05138549) | Prisma Health-Midlands | 2022-09-02 |
| Semaglutide for Alcohol Use Disorder (NCT05520775) | University of North Carolina, Chapel Hill | 2022-09-02 |
| Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma (NCT05214222) | Nanfang Hospital, Southern Medical University | 2022-09-02 |
| Intestinal Microbiome-based Research for the Prevention of Acute GVHD (NCT05808985) | Soonchunhyang University Hospital | 2022-09-02 |
| NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab (NCT04211675) | Nationwide Children's Hospital | 2022-09-01 |
| A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) Versus Camrelizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation (NCT05367687) | Jiangsu HengRui Medicine Co., Ltd. | 2022-09-01 |
| Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells (NCT05214014) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-09-01 |
| Semaglutide Use in Elderly Obese Patients (NCT05302596) | State University of New York at Buffalo | 2022-09-01 |
| Immunological Variables Associated to ICI Toxicity in Cancer Patients (NCT05429866) | Jules Bordet Institute | 2022-09-01 |
| Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) (NCT05702788) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-09-01 |
| A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma (NCT05446688) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-09-01 |
| SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome (NCT05307328) | Sparrow Pharmaceuticals | 2022-09-01 |
| Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion (NCT04271332) | Clinical Research Associates, LLC | 2022-09-01 |
| ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial (NCT05686213) | Radboud University Medical Center | 2022-09-01 |
| A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors (NCT05516914) | Nanjing Leads Biolabs Co.,Ltd | 2022-09-01 |
| A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma (NCT05528679) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2022-09-01 |
| CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies (NCT04282174) | Baptist Health South Florida | 2022-09-01 |
| Immunomodulation With Eltrombopag in ITP (NCT04812483) | University Children's Hospital Basel | 2022-09-01 |
| Naldebain for Control of Post-Cesarean Section Pain (NCT05187520) | E-DA Hospital | 2022-09-01 |
| ComPAS Low-WAZ RCT Mali (NCT05248516) | International Rescue Committee | 2022-09-01 |
| Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer (NCT05511623) | First Affiliated Hospital of Guangxi Medical University | 2022-09-01 |
| Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension (NCT05517993) | Chang Gung Memorial Hospital | 2022-09-01 |
| Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery (NCT04585620) | Allan Vestergaard Danielsen, MD | 2022-09-01 |
| The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia (NCT05494307) | Peking University People's Hospital | 2022-09-01 |
| Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List (NCT04782245) | Hospices Civils de Lyon | 2022-09-01 |
| Efficacy of the antiCD38 Monoclonal Antibody Isatuximab in the Treatment of PCRA by Major ABO Mismatch After Allogeneic Hematopoietic Stem Cell Transplantation (NCT05559827) | Assistance Publique - Hôpitaux de Paris | 2022-09-01 |
| A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection (NCT05514314) | Wu Nan | 2022-09-01 |
| To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer (NCT05491694) | The First Affiliated Hospital with Nanjing Medical University | 2022-09-01 |
| Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy (NCT04845490) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-09-01 |
| A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia (NCT05443724) | AbbVie | 2022-09-01 |
| Olverembatinib for FGFR1-rearranged Neoplasms (NCT05521204) | The First Affiliated Hospital of Soochow University | 2022-09-01 |
| CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC (NCT05724355) | Sun Yat-sen University | 2022-09-01 |
| Intravitreal Sirolimus as Therapeutic Approach to Uveitis (NCT01280669) | Stanford University | 2022-09-01 |
| Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients (NCT03643887) | University of Wisconsin, Madison | 2022-09-01 |
| The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease (NCT02422368) | Iran University of Medical Sciences | 2022-09-01 |
| Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer (NCT04997798) | First Affiliated Hospital of Zhejiang University | 2022-09-01 |
| Clinical Study on the Prevention and Treatment of Postoperative Gastrointestinal Dysfunction by Acupuncture Under ERAS Management Based on Artificial Intelligence Monitoring (NCT07335237) | Jiangsu Province Hospital of Traditional Chinese Medicine | 2022-09-01 |
| [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application (NCT05458544) | FutureChem | 2022-09-01 |
| Transversus Abdominis Plane Blocks With and Without Dexamethasone (NCT05432934) | University of Saskatchewan | 2022-09-01 |
| PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites (NCT05501340) | Second Affiliated Hospital of Soochow University | 2022-09-01 |
| Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery (NCT05518292) | Mansoura University | 2022-09-01 |
| Hepatocyte Microbeads for Acute Liver Failure (NCT05491135) | King's College Hospital NHS Trust | 2022-09-01 |
| Window of Opportunity Trial of Durvalumab (MEDI4736) to Identify Immune Dynamics in Operable Non-small Cell Lung Cancer (NSCLC) (MIRACLE) (NCT05206812) | Yonsei University | 2022-09-01 |
| HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL (NCT03947775) | University Health Network, Toronto | 2022-09-01 |
| Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors (NCT05533697) | ModernaTX, Inc. | 2022-09-01 |
| Booster Study of COVID-19 Protein Subunit Recombinant Vaccine (NCT05525208) | PT Bio Farma | 2022-09-01 |
| Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction (NCT05445921) | Washington University School of Medicine | 2022-09-01 |